Try one of the below options to narrow down your search.
 |
Documents may be browsed by date, eg; Today, May, 2013.
Past years can be browsed too, eg; 2012, 2011, 2010, 2009 ...
Documents can be searched within a period by browsing to the date and then using the search form; or by direct links, eg; Media releases from 2013
Document tags (shown below the document date, eg; Schedule, SAForms, consultation ...) have highest priority when search results are ranked, followed by title, abstract and full text of document.
Parentheses and the keywords and, or and not have special meaning in search terms. And is implicit and can be omitted; or must be specified.
Remember to group or statements with parentheses if they are beside and statements.
Search examples
- consultation
- Search for consultations
- media and not antibiotics
- Search for media related documents that don't mention antibiotics.
- (media or consultation) and vaccines
- Search for media releases and consultation documents mentioning vaccinations.
Search term: notification
2011 / 06
Your search is limited to one month, search the whole site for notification.
PHARMAC documents that matched your search:
June Tender Notification; Contact: Notifications
(6 pages, 120 KB)
2011/06/30
30 June 2011 TENDER RESULTS The PHARMAC Board (or Chief Executive under Delegated Authority) has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2010/11 Invitation to Tender, dated 2…
Allopurinol tab 300 mg, Symbicort Turbuhaler and Ovestin Cream; Contact: Notifications
(2 pages, 157 KB)
2011/06/28
FACSIMILE To Fax From Subject Date All New Zealand Pharmacies, IPA Pharmacy Facilitators and Wholesalers Autodial Kaye Wilson, Schedule Analyst Allopurinol tab 300 mg, Symbicort Turbuhaler, and Ovestin cream 28 June 2011 Pages 2 Dear Pharmacist and Wholesaler Allopurinol 300…
Response regarding funding for Myozyme for adult-onset Pompe Disease
(4 pages, 105 KB)
2011/06/17
17 June 2011 Myozyme funding for Pompe Disease in New Zealand We have received a number of emails, letters and telephone calls from people seeking information about funding for alglucosidase alfa (Myozyme), an expensive enzyme replacement therapy which is not…
Changes in the listings for budesonide with eformoterol and eformoterol fumarate inhalers; Contact: Christine Chapman
(2 pages, 111 KB)
2011/06/16
16 June 2011 Changes in the listings for budesonide with eformoterol and eformoterol fumarate inhalers Summary We previously notified that under a 2006 Agreement the prices at which Symbicort Turbuhaler, Vannair and Oxis Turbuhaler are supplied were to be reduced…
Dabigatran bleeding management
(1 page, 86 KB)
2011/06/10
Guidelines for management of bleeding with dabigatran - for possible inclusion into local management protocols The following guidelines have been prepared by PHARMAC with the assistance of practicing specialists in response to requests for information. They are provided to assist…
Dabigatran testing and perioperative management
(2 pages, 129 KB)
2011/06/10
Guidelines for testing and perioperative management of dabigatran - for possible inclusion into local management protocols The following guidelines have been prepared by PHARMAC with the assistance of practicing specialists in response to requests for information. They are provided to…
Dabigtran funding approved; Contact: Sueanne Yee
(3 pages, 120 KB)
2011/06/10
10 June 2011 Dabigatran funding approved PHARMAC is pleased to announce the approval of an agreement with Boehringer Ingelheim (NZ) Limited to fund dabigatran (Pradaxa) without Special Authority restriction, from 1 July 2011. Dabigatran is an oral anticoagulant approved for…
Proposal to remove docetaxel Special Authority approved; Contact: Jackie Evans
(1 page, 106 KB)
2011/06/10
10 June 2011 Approval of proposal to widen funded access to docetaxel PHARMAC is pleased to announce approval of the proposal to widen funded access to the Pharmaceutical Cancer Treatment (PCT) docetaxel from 1 July 2011 by removing the Special…
Olanzapine depot injection, raloxifene and teriparatide approved; Contact: Geraldine MacGibbon
(4 pages, 135 KB)
2011/06/08
8 June 2011 Funding of olanzapine depot injection, raloxifene and teriparatide approved PHARMAC is pleased to announce the approval of an agreement with Eli Lilly and Company (NZ) Limited to fund a new depot antipsychotic injection and two new treatments…
Decisions relating to Musculoskeletal System pharmaceuticals; Contact: Geraldine MacGibbon
(2 pages, 111 KB)
2011/06/02
2 June 2011 Decisions relating to Musculoskeletal System pharmaceuticals PHARMAC is pleased to announce the approval of some, but not all, aspects of a proposal involving Musculoskeletal System pharmaceuticals that was the subject of a consultation letter dated 27 April…
